Brillant Blue Versus Indocyanine Green for Macular Hole Surgery

The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery

Status: Completed

Conditions: Idiopathic Macular Holes

Treatments: Procedure: Brillant Blue; Procedure: Indocyanine Green

Study type: Interventional

Funder types: Other

Identifiers

NCT00757471

FR-5-CI-2008

Details and patient eligibility

About

Macular Hole Surgery with two different Dyes

Enrollment: 60 patients

Sex: All

Ages: 60+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Idiopathic stage 3 and 4 macular holes
• Stage 2 macular holes, followed up for at least 6 months
• Pseudophakic and phakic eyes
• Age over 60 years

Exclusion criteria

• Traumatic macular holes
• Secondary macular holes
• Severe ocular diseases

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

60 participants in 2 patient groups

Group 1

Active Comparator group

Description:

Brillant Blue

Treatment:

Procedure: Brillant Blue

Group 2

Active Comparator group

Description:

Indocyanine Green

Treatment:

Procedure: Indocyanine Green